Acorn is a Toronto-based healthcare technology company focused on giving everyone access to personalized regenerative medicine with the world’s first non-invasive, follicle-based cell cryopreservation service. Our services are available to clients at partner clinics across North America and as a part of employee benefits programs at pioneering businesses and partners.
The Acorn team brings a breadth of expertise in areas ranging from stem cell research, business strategy, to regenerative medicine. Not only are we committed to being your cell cryopreservation resource, but our science team is actively developing cell based therapies for you to leverage when you need them.
As a pioneer and entrepreneur in the field of regenerative medicine, Dr. Drew Taylor is committed to making the latest advancements in this field accessible and personalized for everyone.
Prior to co-founding Acorn in 2017, Drew spent several years as Chief Science Officer at Epic Capital Management working across the flourishing biotech start-up community. Previous to his role at Epic Capital, Drew spent time as part of the Mount Sinai Hospital Bioengineering of Skeletal Tissues Team.
Drew received his undergraduate and Master’s degree in Molecular, Cellular, Developmental Biology at the University of Michigan and went on to complete a PhD in Biomedical Engineering from the University of Toronto.
Dr. Taylor has also enjoyed a successful career in professional minor league baseball as a pitcher for both the Toronto Blue Jays and the Philadelphia Phillies, charting parallel paths across both professional sports and science.
William is a corporate strategy and finance leader with experience scaling businesses in multiple industries. Bringing years of experience in mergers and acquisitions, optimizing financial systems, and constructing efficient team, he leads commercial operations at Acorn. His broad areas of expertise include business development and growth, operational excellent, internal structure and leadership. Prior to Acorn, he was responsible for corporate development at Busbud in the travel sector in Montreal which has expanded to over 80 countries and 14,000 cities and Perativ in the financial sector in Toronto which exited to Morgan Stanley Capital Partners.
Crystal brings nearly 25 years of experience in marketing, corporate communications/PR and commercial operations for global Fortune 500 companies and public start-ups. Most recently, Crystal served on the Board of Elevai Labs, a topical regenerative skin care company. Crystal was Chief Marketing Officer at Evolus where she led the re-launch of Jeuveau®, a disruptor brand to BOTOX® Cosmetic. Prior to Evolus, Crystal was Head of Global Strategic Marketing for Sienna Biopharmaceuticals, a clinical-stage medical dermatology company. Crystal also spent more than a decade at Allergan in various leadership roles in US and International marketing and communications where she gained significant commercial launch experience with the company’s flagship BOTOX franchise and leading aesthetics brands.
Meet our advisors, leaders in personalized regenerative medicine. They are a group of experts and specialists, passionate about making regenerative medicine accessible to everyone.
Assistant Professor and Director of Dermatologic Surgery at the University of Toronto, Co-Director of the Non-Melanoma Skin Cancer Clinic at Women College Hospital.
.png)
Globally recognised for her research and clinical work in cosmetic surgery, including pioneering the cosmetic use of botulinum A exotoxin.
.png)
Board Certified Ophthalmologist and World leader in Medical Aesthetics.
.png)
Owner, Beauty by Buford | 3X published author | Named one of America’s top surgeons by Consumers’ Research Council of America
.png)
Orthopedic Surgeon, Toronto Blue Jays | Orthopedic Surgeon, Scarborough Health Network
.png)
Assistant Professor, Division of Orthopaedic Surgery, McGill University
.png)
Regulatory Advisor, Director Regulatory Affairs and Quality Assurance, Molli Surgical
.png)
VP Product Development Lineage Cell Therapeutics | VP R&D Aivita Biomedical
.png)
Dept. of Comparative Biology and Experimental Medicine, University of Calgary
.png){kind=small}
